Business Wire

Wemade Introduces New Updates to ‘MIR4’

2.11.2021 06:15:00 EET | Business Wire | Press release

Share

MMORPG ‘MIR4’, with over one million concurrent users, will experience a large-scale update on November 2nd. It will include a release of a new class, Arbalist - a crossbow fighter with extremely destructive powers – and the unveiling of the Class Change system. Additional content includes a huge field boss, Crimson Emperor Utukan, and a new growth system – Solitude Training. Furthermore, XDRACO items will be updated and the DSP (DRACO Staking Program) official service will be launched.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211101006046/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

MMORPG ‘MIR4’, with over one million concurrent users, will experience a large-scale update. It will include a release of a new class, Arbalist, a crossbow fighter with extremely destructive powers and the unveiling of the Class Change system. Additional content includes a huge field boss, Crimson Emperor Utukan, and a new growth system, Solitude Training. Furthermore, XDRACO items will be updated and the DSP (DRACO Staking Program) official service will be launched. (Graphic: Business Wire)

'Arbalist' is the only long-range physical attack type class in ‘MIR4’. Arbalist demonstrates extreme destructive power and high levels of survivability using a crossbow combined with martial arts. Groups of monsters can also be hunted efficiently using powerful Area of Effect skills and players can enjoy a new gameplay style with a sniping component that is a new experience for ‘MIR4’ users.

The Class Change system can change an existing character’s class while maintaining growth stats. Players can change and choose between the five classes, including the new class, Arbalist, as well as Warrior, Sorcerer, Taoist, and Lancer. The huge field boss, Crimson Emperor Utukan, will also be released. Crimson Emperor Utukan appears every Friday at 11 PM in each region server’s time zone in Crimson Abaddon, located on the fourth floor of Snake Valley. Players who are successful in battle with the field boss will receive 50 treasure chests.

Solitude Training is a growth system that can strengthen the four Blood Vessels; Conception Vessel, Governing Vessel, Thoroughfare Vessel, and Girdle Vessel for players at level 70 and above. Blood Vessels can be strengthened up to Tier 10 by upgrading using energy and materials.

Additionally, XDRACO items marked with the DRACO emblem will be updated and DSP official service will begin. The XDRACO items can be obtained through in-game item drops and DSP, and can be traded through EXCHANGE BY DRACO. Players can deposit their DRACO to DSP and acquire XDRACO items through a draw. The probability of winning the item increases as the deposit amounts and period increases, and those who do not win the draw will be refunded 100% of the deposited DRACO.

From my battle, to our war! Visit the official site for more information on the coming updates.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contact:
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 08:30:00 EEST | Press release

SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye